medication

Escitalopram

Also known as: Lexapro

Chemical structure of Escitalopram (PubChem CID 146570)
Structure via PubChem
Half-life
30 h
Typical timing
morning
Food rule
either
Default unit
mg

Overview

Escitalopram is a medication classified as a selective serotonin reuptake inhibitor (SSRI). It is primarily used to treat major depressive disorder (MDD) in adults and adolescents aged 12 years and older, and generalized anxiety disorder (GAD) in adults. Escitalopram is the S-enantiomer of the racemic mixture citalopram, meaning it is the active component responsible for citalopram's therapeutic effects. The medication is available by prescription only and comes in oral tablet and solution forms. It is known by various brand names, most notably Lexapro. (FDA label, DrugBank)

Deep dive

Tap a section to expand.

Known interactions

  • Category rule: supplement × medication
    Note

    Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).

    Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

  • Category rule: vitamin × medication
    Note

    Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).

    Specific pairs are checked against a licensed source; confirm with your provider.

  • Compound-pair rule
    Avoid

    Combining SSRIs/SNRIs with MAOIs can cause life-threatening serotonin syndrome.

    Do not combine. Allow at least 14 days between stopping one and starting the other (5 weeks for fluoxetine).

  • Compound-pair rule
    Avoid

    Combining SSRIs/SNRIs with MAOIs can cause life-threatening serotonin syndrome.

    Do not combine. Allow at least 14 days between stopping one and starting the other (5 weeks for fluoxetine).

  • Compound-pair rule
    Avoid

    Combining SSRIs/SNRIs with MAOIs can cause life-threatening serotonin syndrome.

    Do not combine. Allow at least 14 days between stopping one and starting the other (5 weeks for fluoxetine).

  • Compound-pair rule
    Avoid

    Combining SSRIs/SNRIs with MAOIs can cause life-threatening serotonin syndrome.

    Do not combine. Allow at least 14 days between stopping one and starting the other (5 weeks for fluoxetine).

  • Compound-pair rule
    Avoid

    5-HTP raises serotonin and layered onto an SSRI/SNRI risks serotonin syndrome.

    Avoid combining 5-HTP with prescription serotonergic antidepressants.

  • Compound-pair rule
    Caution

    Additional serotonin precursor with an SSRI/SNRI can push serotonin too high.

    Do not combine without a prescribing clinician's guidance.

  • Compound-pair rule
    Avoid

    St John's Wort has serotonergic activity and induces CYP3A4, altering SSRI levels.

    Avoid combining.

Frequently asked

Sources referenced

["U.S. Food and Drug Administration (FDA) label for Lexapro (escitalopram)", "National Institutes of Health (NIH) Office of Dietary Supplements (ODS)", "MedlinePlus - National Library of Medicine", "PubChem - National Library of Medicine", "Mayo Clinic", "Cochrane Library", "DrugBank"]

Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.

Related compounds

Others in the medication category or studied for the same goals.

Track Escitalopram in Stackwise

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →